Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.33 |
| ▸ | JAK2 | O60674 | 1/20 | 0.32 |
| ▸ | JAK3 | P52333 | 1/20 | 0.32 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.32 |
| ▸ | MARK3 | P27448 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.31 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.31 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.30 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.30 |
| ▸ | PRKD2 | Q9BZL6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31423943 | 0.83 | NTRK1 (0.35) | NTRK1JAK2JAK3MARK3 | |
| SCHEMBL31423920 | 0.82 | ATR (0.33) | MAPK8MEN1CYP1A2CYP2C19KMT2A | |
| SCHEMBL31423998 | 0.81 | JAK2 (0.38) | MEN1CYP1A2CYP2C19KMT2AJAK2 | |
| SCHEMBL31423902 | 0.80 | NTRK1 (0.34) | NTRK1 | |
| SCHEMBL31423948 | 0.80 | NTRK1 (0.34) | NTRK1 | |
| SCHEMBL31423937 | 0.80 | NTRK1 (0.34) | NTRK1 | |
| SCHEMBL31423966 | 0.80 | NTRK1 (0.34) | NTRK1 | |
| SCHEMBL31423965 | 0.80 | MAPK8 (0.33) | MAPK8JAK2JAK3PTK2ADORA2A | |
| SCHEMBL31423962 | 0.80 | MAPK8 (0.33) | MAPK8JAK2JAK3PTK2KDM5B | |
| SCHEMBL31423883 | 0.80 | MAPK8 (0.33) | MAPK8JAK2JAK3PTK2KDM5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025054386-A1 | CDK2 INHIBITORS AND USES THEREOF | ODYSSEY THERAPEUTICS, INC. (US) | 2025-03-13 | — | — | WO | disclosed |